(Updated - May 11, 2023 4:31 PM EDT)

Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $29.62 million versus the consensus estimate of $30.84 million.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

Earnings